The Mumbai-based firm has also entered into definitive agreements with Indfrag to acquire the balance stake in couple of months.
"The acquisition provides us distribution capability in markets like South Korea and US. The buyout would also help us gain access to extracts which are used in production of nutraceutical products," OmniActive Health Technologies Managing Director and CEO Sanjaya Mariwala told PTI.
The buyout also provides the company with additional production capacity as well as bolster its overall product portfolio, he added.
The acquisition includes all products related to Indfrag's food and nutrition business. OmniActive has acquired Indfrag by raising funds from various sources including the recent PE investment by Everstone.
Also Read
Industry sources pegged the deal size at around USD 80 million.
Indfrag has a significant presence in the international market as a leading supplier of high quality botanical and plant extracts from India and South East Asia for the dietary supplement and nutraceuticals industry.
"By coming together, both companies intend to spearhead industry efforts to bring to our customers fully authenticated and validated extracts that meet the emerging standards of safety, reliability, transparency and traceability," Mariwala said.
Indfrag will operate as an independent business, and OmniActive and Indfrag teams will continue to manage their respective product lines and customers.
Besides Mariwala, Deep Mishra, Managing Director at Everstone India and Chaitanya Desai, Chief Operating Officer at OmniActive, will be joining the Board of Indfrag.
Disclaimer: No Business Standard Journalist was involved in creation of this content